Page 1 VBS App 4E 30 Jun 202 6 Rule 4.3A Name of entity VECTUS BIOSYSTEMS LIMITED ABN: 54 117 526 137 Reporting period: 30 June 2026 Previous period: 30 June 2025 Results for announcement to the market AUD Revenues from ordinary activities up 478.7% to 2,767,048 up 183.7% to...
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Cleansing Notice
- Application for quotation of securities - VBS
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Placement of Shares
- Appointment of Dr Tara Speranza as CEO & CTO
Later from Vectus Biosystems
- Full Year Statutory Accounts
- Change of Director's Interest Notice - MS
- Date of 2026 Annual General Meeting
- Annual Report to shareholders
- 2026 Corporate Governance Statement & Appendix 4G
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems